Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.
Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...